BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 2196078)

  • 21. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
    Lever LR; Farr PM
    Br J Dermatol; 1994 Aug; 131(2):215-9. PubMed ID: 7917985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS;
    J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Position paper--PUVA therapy. American Academy of Dermatology.
    Bickers DR
    J Am Acad Dermatol; 1983 Feb; 8(2):265-70. PubMed ID: 6402528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
    Stern RS; Lunder EJ
    Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
    Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photocarcinogenicity of drugs.
    Stern RS
    Toxicol Lett; 1998 Dec; 102-103():389-92. PubMed ID: 10022284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy.
    Smith G; Wilkie MJ; Deeni YY; Farr PM; Ferguson J; Wolf CR; Ibbotson SH
    Br J Dermatol; 2007 Dec; 157(6):1230-4. PubMed ID: 17916200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy.
    Weinstock MA; Coulter S; Bates J; Bogaars HA; Larson PL; Burmer GC
    Arch Dermatol; 1995 Jun; 131(6):701-4. PubMed ID: 7778923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
    Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
    Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PUVA-treated psoriatic skin as a model for cutaneous wrinkling assessed by skin replicas.
    Brazzelli V; Borroni G; Berardesca E; Romano E; Vignoli GP; Rabbiosi G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():162-3. PubMed ID: 8073823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photochemotherapy in psoriasis and other skin diseases.
    Adrian RM
    Am Fam Physician; 1981 May; 23(5):95-100. PubMed ID: 7234635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of the fraction of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psoralen/ultraviolet-A radiation (PUVA).
    Moscicki RA; Morison WL; Parrish JA; Bloch KJ; Colvin RB
    J Invest Dermatol; 1982 Sep; 79(3):205-8. PubMed ID: 6809841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
    van de Kerkhof PC; de Rooij MJ
    Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.